Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor

Diabetes Technol Ther. 2003;5(1):27-31. doi: 10.1089/152091503763816436.

Abstract

Continuous glucose monitoring has the potential to improve glucose management and reduce the risk of hypoglycemia in individuals with diabetes. Accurate sensors may also allow the development of a closed-loop insulin delivery system. The purpose of this work was to determine the delay time associated with a subcutaneous glucose sensor during rapidly changing glucose excursions. Subcutaneous glucose sensors (Medtronic MiniMed, Inc., Northridge, CA) were inserted in five healthy men. After a 2-h stabilization period, a 3-h hyperglycemic (approximately 11 mM) clamp was performed followed by a 90-min period in which plasma glucose was allowed to decline to as low as 2.8 mM. Sensors were calibrated using two points (basal and hyperglycemia), and the calibrated sensor glucose measurements were compared with those from a reference analyzer (Beckman Instruments, Fullerton, CA). Response time was estimated from a first-order kinetic model. Plasma glucose levels, determined with the subcutaneous sensor, were highly correlated with those obtained with the reference glucose analyzer (r(2) = 0.91, p < 0.001; mean absolute difference of approximately 8%). The half-time for the sensor response was estimated to be 4.0 +/- 1.0 min. The subcutaneous glucose sensor has the potential to facilitate the detection of hypoglycemia and improve overall glycemic control when used in a real-time monitor. The rapid response should be sufficient to allow a fully automated closed-loop insulin delivery system to be developed based on the subcutaneous sensing site.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Biosensing Techniques
  • Blood Glucose / analysis*
  • Blood Glucose / metabolism
  • Diabetes Mellitus / blood*
  • Diabetes Mellitus / drug therapy
  • Glucose Clamp Technique
  • Humans
  • Hypoglycemia / prevention & control
  • Male
  • Middle Aged
  • Monitoring, Ambulatory
  • Reference Values
  • Regression Analysis

Substances

  • Blood Glucose